PRESS RELEASE
News
-
-
PRESS RELEASE
STS Group AG continues positive development with significant increase in sales revenue and earnings in the first quarter of 2024
STS Group AG reports a significant increase in sales revenue and earnings in the first quarter of 2024 despite economic challenges. Full-year guidance reaffirmed -
PRESS RELEASE
Mutares has successfully completed the acquisition of FSL Ladenbau GmbH
Mutares SE & Co. KGaA successfully completes acquisition of FSL Ladenbau GmbH, a leading shopfitting provider in Northern Germany, strengthening Ganter Group with synergies and EUR 15 million in planned revenues for 2024 -
-
PRESS RELEASE
Transgene – Premier patient inclus dans la partie Phase II de l’étude randomisée de Phase I/II de son actif phare TG4050, un vaccin thérapeutique individualisé évalué dans les cancers de la tête et du cou
Transgene annonce l'inclusion du premier patient dans la partie Phase II de l'étude randomisée de Phase I/II pour son vaccin TG4050 dans les cancers de la tête et du cou. Démarrage de la sélection des patients pour cette étude internationale -
-
PRESS RELEASE
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead Cancer Vaccine TG4050 in Head and Neck Cancer
Transgene enrolls first patient in Phase II of randomized Phase I/II trial for cancer vaccine TG4050 in head and neck cancer, with completion expected in Q4 2025 -
-
-
